Avid Bioservices Inc (CDMO)

[DrRocker]

The original comment was pure speculation based on zero facts, now you're asking why management has agreed to a bad deal?

I am opining that management's decision to go it alone in the clinical development of Bavituximab rather than partner as they stated was their preference on multiple occasions is the reason most long term shareholders stand little chance of recouping their losses much less achieving the astronomical value many of us thought would be the case.